Frank Cichocki

Frank Cichocki

Auto-generated profile, based on publicly available information

Frank Cichocki

University of Minnesota

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2024 in Nature Immunology
Verified
Journal Article
Open access
PDF file
LRLucas Rebuffet
Lucas Rebuffet
JMJanine E. Melsen
Janine E. Melsen
BEBertrand Escalière
Bertrand Escalière
DBDaniela Basurto-Lozada
Daniela Basurto-Lozada
ABAvinash Bhandoola
Avinash Bhandoola
ÉVÉric Vivier
Éric Vivier
Natural killer (NK) cells are innate lymphoid cells (ILCs) contributing to immune responses to microbes and tumors. Historically, their classification hinged on a limited array of surface protein markers. Here, we used single-cell RNA sequencing (scRNA-seq) and cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) to dissect the heterogeneity of NK cells. We identified three prominent NK cell subsets in healthy human blood: NK1, NK2 and NK3, further differentiated into six distinct subgroups. Our findings delineate the molecular characteristics, key transcription factors, biological functions, metabolic traits and cytokine responses of each subgroup. These data also suggest two separate ontogenetic origins for NK cells, leading to divergent transcriptional trajectories. Furthermore, we analyzed the distribution of NK cell subsets in the lung, tonsils and intraepithelial lymphocytes isolated from healthy individuals and in 22 tumor types. This standardized terminology aims at fostering clarity and consistency in future research, thereby improving cross-study comparisons.

4 November 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
FCFrank Cichocki
Frank Cichocki
RBRyan Bjordahl
Ryan Bjordahl
SGSvetlana Gaidarova
Svetlana Gaidarova
SMSajid Mahmood
Sajid Mahmood
RARamzey Abujarour
Ramzey Abujarour
JMJeffrey Miller
Jeffrey Miller
Natural killer cells derived from iPSCs prime T cells for anti–PD-1 immune checkpoint therapy.

12 August 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AMAimee Merino
Aimee Merino
BZBin Zhang
Bin Zhang
PDPhilip Dougherty
Philip Dougherty
XLXianghua Luo
Xianghua Luo
JWJinhua Wang
Jinhua Wang
FCFrank Cichocki
Frank Cichocki
A population of NK cells expressing the activating receptor NKG2C and the maturation marker CD57 expands in response to human CMV (HCMV) infection. CD3–CD56dimCD57+NKG2C+ NK cells are similar to CD8+ memory T cells with rapid and robust effector function upon restimulation, persistence, and epigenetic remodeling of the IFNG locus. Chronic antigen stimulation drives CD8+ memory T cell proliferation, while also inducing genome-wide epigenetic reprograming and dysfunction. We hypothesized that chronic stimulation could similarly induce epigenetic reprograming and dysfunction in NK cells. Here, we show that chronic stimulation of adaptive NK cells through NKG2C using plate-bound agonistic Abs in combination with IL-15 drove robust proliferation and activation of CD3–CD56dimCD57+NKG2C+ NK cells, while simultaneously inducing high expression of the checkpoint inhibitory receptors LAG-3 and PD-1. Marked induction of checkpoint inhibitory receptors was also observed on the surface of adaptive NK cells cocultured with HCMV-infected endothelial cells. Chronically stimulated adaptive NK cells were dysfunctional when challenged with tumor targets. These cells exhibited a pattern of epigenetic reprograming, with genome-wide alterations in DNA methylation. We believe our study has important implications for cancer immunotherapy and propose that exhausted NK cells could be targeted with inhibitory checkpoint receptor blockade.

29 August 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
FCFrank Cichocki
Frank Cichocki
BGBartosz Grzywacz
Bartosz Grzywacz
JMJeffrey S. Miller
Jeffrey S. Miller
CD3−CD56+ NK cells develop from CD34+ hematopoietic progenitors (HPCs) in vivo, and this process can be recapitulated in vitro. The prevailing model is that human NK cell development occurs along a continuum whereby common lymphocyte progenitors (CLPs) gradually downregulate CD34 and upregulate CD56. Acquisition of CD94 marks commitment to the CD56bright stage, and CD56bright NK cells subsequently differentiate into CD56dim NK cells that upregulate CD16 and killer immunoglobulin-like receptors (KIR). Support for this linear model comes from analyses of cell populations in secondary lymphoid tissues and in vitro studies of NK cell development from HPCs. However, several lines of evidence challenge this linear model and suggest a more branched model whereby different precursor populations may independently develop into distinct subsets of mature NK cells. A more definitive understanding of human NK cell development is needed to inform in vitro differentiation strategies designed to generate NK cells for immunotherapy. In this review, we summarize current evidence supporting the linear and branched models of human NK cell development and the challenges associated with reaching definitive conclusions.

9 September 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
KWKarrune V. Woan
Karrune V. Woan
HKHansol Kim
Hansol Kim
RBRyan Bjordahl
Ryan Bjordahl
ZDZachary B. Davis
Zachary B. Davis
SGSvetlana Gaidarova
Svetlana Gaidarova
FCFrank Cichocki
Frank Cichocki

4 March 2021 in Science Immunology
Verified
Journal Article
Closed access
PDF file
THTim D. Holmes
Tim D. Holmes
RPRam Vinay Pandey
Ram Vinay Pandey
EHEric Y. Helm
Eric Y. Helm
HSHeinrich Schlums
Heinrich Schlums
HHHongya Han
Hongya Han
YBYenan T. Bryceson
Yenan T. Bryceson
Epigenetic landscapes can provide insight into regulation of gene expression and cellular diversity. Here, we examined the transcriptional and epigenetic profiles of seven human blood natural killer (NK) cell populations, including adaptive NK cells. The BCL11B gene, encoding a transcription factor (TF) essential for T cell development and function, was the most extensively regulated, with expression increasing throughout NK cell differentiation. Several Bcl11b-regulated genes associated with T cell signaling were specifically expressed in adaptive NK cell subsets. Regulatory networks revealed reciprocal regulation at distinct stages of NK cell differentiation, with Bcl11b repressing RUNX2 and ZBTB16 in canonical and adaptive NK cells, respectively. A critical role for Bcl11b in driving NK cell differentiation was corroborated in BCL11B-mutated patients and by ectopic Bcl11b expression. Moreover, Bcl11b was required for adaptive NK cell responses in a murine cytomegalovirus model, supporting expansion of these cells. Together, we define the TF regulatory circuitry of human NK cells and uncover a critical role for Bcl11b in promoting NK cell differentiation and function.